96 related articles for article (PubMed ID: 5526855)
21. Inhibition by dexamethasone of erythropoietin-induced amplification of the erythropoietin-responsive cell compartment.
Giglio MJ; Alippi RM; Bozzini CE
Exp Hematol; 1981 Apr; 9(4):444-8. PubMed ID: 7238657
[TBL] [Abstract][Full Text] [Related]
22. Selective eradication of erythropoiesis by actinomycin D as the result of interference with hormonally controlled effector pathway of cell differentiation.
Reissmann KR; Ito K
Blood; 1966 Aug; 28(2):201-12. PubMed ID: 5913051
[No Abstract] [Full Text] [Related]
23. Effect of erythropoietin on early recovery of erythropoiesis in mice after sublethal dose of 5-fluorouracil.
Reissmann KR; Samorapoompichit S
Proc Soc Exp Biol Med; 1968 Jul; 128(3):898-901. PubMed ID: 5668151
[No Abstract] [Full Text] [Related]
24. Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo.
Thawani N; Tam M; Chang KH; Stevenson MM
Exp Hematol; 2006 Nov; 34(11):1451-61. PubMed ID: 17046564
[TBL] [Abstract][Full Text] [Related]
25. Red blood cell erythropoietin, not plasma erythropoietin, concentrations correlate with changes in hematological indices in horses receiving a single dose of recombinant human erythropoietin by subcutaneous injection.
Singh AK; Gupta S; Barnes A; Carlson JM; Ayers JK
J Vet Pharmacol Ther; 2007 Apr; 30(2):175-8. PubMed ID: 17348906
[No Abstract] [Full Text] [Related]
26. Erythropoietin dose requirements when converting from subcutaneous to intravenous administration among patients on hemodialysis.
Moist LM; Muirhead N; Wazny LD; Gallo KL; Heidenheim AP; House AA
Ann Pharmacother; 2006 Feb; 40(2):198-203. PubMed ID: 16449549
[TBL] [Abstract][Full Text] [Related]
27. In vitro behavior of stem cells.
Krantz SB; Fried W
J Lab Clin Med; 1968 Jul; 72(1):157-64. PubMed ID: 5659540
[No Abstract] [Full Text] [Related]
28. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
Pizzarelli F; David S; Sala P; Icardi A; Casani A
Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
[TBL] [Abstract][Full Text] [Related]
29. [Hematopoiesis--promoting effect of thyroid hormone].
Shirakura T; Yoshimatsu H; Hirai A
Igaku To Seibutsugaku; 1971 Mar; 82(3):119-22. PubMed ID: 5165294
[No Abstract] [Full Text] [Related]
30. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
Sadjadi SA
Am J Kidney Dis; 1995 Dec; 26(6):1000-1. PubMed ID: 7503060
[No Abstract] [Full Text] [Related]
31. Erythropoietin excretion in a hypopituitary patient. Effects of testosterone and vasopressin.
Jepson JH; McGarry EE; Lowenstein L
Arch Intern Med; 1968 Sep; 122(3):265-70. PubMed ID: 5671108
[No Abstract] [Full Text] [Related]
32. Erythropoietin excretion in man following androgens.
Alexanian R; Vaughn WK; Ruchelman MW
J Lab Clin Med; 1967 Nov; 70(5):777-85. PubMed ID: 6055763
[No Abstract] [Full Text] [Related]
33. The erythropoietin content of plasma from sheep treated with nitrogen mustard.
Magid E; Hansen P
Scand J Clin Lab Invest; 1966; 18(3):347-52. PubMed ID: 5919198
[No Abstract] [Full Text] [Related]
34. [Erythroidic response to erythropoietin in thyroid deficient rats].
Barrio Rendo ME
C R Seances Soc Biol Fil; 1972; 166(8):1215. PubMed ID: 4660189
[No Abstract] [Full Text] [Related]
35. Mechanism underlying the inhibitory effect of dexamethasone on in vivo erythropoiesis.
Giglio MJ; Alippi RM; Bozzini CE
Exp Hematol; 1980 Aug; 8(7):911-6. PubMed ID: 16398023
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
Raja R; Bloom E; Johnson R
Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
[TBL] [Abstract][Full Text] [Related]
37. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
Barclay PG; Fischer ER; Harris DC
Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin response and route of administration.
Taylor JE; Belch JJ; Fleming LW; Mactier RA; Henderson IS; Stewart WK
Clin Nephrol; 1994 May; 41(5):297-302. PubMed ID: 8050210
[TBL] [Abstract][Full Text] [Related]
39. [Correction of anemia in hemodialysis, effect of intravenous iron without erythropoietin].
Alvo M; Elgueta L; Aragón H; Cotera A
Rev Med Chil; 2002 Aug; 130(8):865-8. PubMed ID: 12360794
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin.
Paul J
Br J Haematol; 1969 Sep; 17(3):303. PubMed ID: 5806444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
